Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMERICAN EXPRESS COAXP · Entity 2839 | Director | May 05, 2026 | May 07, 2026 |
| HP INCHPQ · Entity 642 | Chief Financial Officer | August 05, 2026 | August 07, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMERICAN EXPRESS CO
Report date May 05, 2026 · Filed May 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Share Equivalent UnitsSEC Table II · derivative / convertible security | Direct | 9,256.498 |
Reported balance
After 2026-05-05 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-05 · Grant · Acquired 742.115 · Balance 9,256.498 F1: Each Share Equivalent Unit reflects the value of one common share. F2: The reported Share Equivalent Units were acquired pursuant to the Directors' Deferred Compensation Plan and will be settled in cash following termination of service as a Director. F3: The Share Equivalent Units are convertible immediately upon termination of service as a Director and have no expiration date. F4: Includes Share Equivalent Units acquired pursuant to a dividend reinvestment feature of the Directors' Deferred Compensation Plan and/or the 2003 Share Equivalent Unit Plan for Directors. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Share Equivalent Unit reflects the value of one common share.
F2: The reported Share Equivalent Units were acquired pursuant to the Directors' Deferred Compensation Plan and will be settled in cash following termination of service as a Director.
F3: The Share Equivalent Units are convertible immediately upon termination of service as a Director and have no expiration date.
F4: Includes Share Equivalent Units acquired pursuant to a dividend reinvestment feature of the Directors' Deferred Compensation Plan and/or the 2003 Share Equivalent Unit Plan for Directors.
HP INC
Report date August 05, 2026 · Filed August 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 199,707 |
Ending reported balance
After 2026-08-05 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-08-05 · Exercise / conversion · Acquired 166,746 · Balance 268,880 Row 2 · 2026-08-05 · Tax withholding · Disposed 69,173 · Balance 199,707 F1: Shares withheld by HP to satisfy tax withholding upon vesting of Restricted Stock Units ("RSUs"). |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 152,672 |
Reported balance
After 2026-08-05 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-08-05 · Exercise / conversion · Disposed 166,746 · Balance 152,672 F2: Each RSU represents a contingent right to receive one share of HP common stock. F3: On 8/5/2024, the reporting person was granted 458,015 RSUs, 1/3 of which vest annually over 3 years on 8/5/2025, 8/5/2026 and 8/5/2027, respectively. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 14,074 dividend equivalent units. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld by HP to satisfy tax withholding upon vesting of Restricted Stock Units ("RSUs").
F2: Each RSU represents a contingent right to receive one share of HP common stock.
F3: On 8/5/2024, the reporting person was granted 458,015 RSUs, 1/3 of which vest annually over 3 years on 8/5/2025, 8/5/2026 and 8/5/2027, respectively. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 14,074 dividend equivalent units.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Medtronic plc
Report date August 02, 2024 · Filed August 06, 2024
Section 16 reporting ended · disclosed 2024-08-06. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 46,730 |
Ending reported balance
After 2024-08-02 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2024-08-02 · Exercise / conversion · Acquired 7,132 · Balance 53,459 F1: Represents shares issued upon the settlement of performance-vesting restricted stock units granted on August 2, 2021 and earned dividend equivalents. Row 2 · 2024-08-02 · Tax withholding · Disposed 3,148 · Balance 50,311 F2: Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units that vested on August 2, 2024. Row 3 · 2024-08-02 · Tax withholding · Disposed 3,581 · Balance 46,730 F3: Represents shares withheld for taxes upon the vesting of restricted stock units previously reported on Table I. |
| Performance Share UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2024-08-02 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2024-08-02 · Exercise / conversion · Disposed 7,132 · Balance 0 F5: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F6: The performance share units vested on August 2, 2024. |
| Ordinary SharesSEC Table I · non-derivative | IndirectJeffrey S. Parkhill 2021 Irrevocable Trust | 49,859 |
Reported balance
Holding disclosure · report date 2024-08-02 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 49,859 F4: These shares are held in the Jeffrey S. Parkhill 2021 Irrevocable Trust, of which the insider is the trustee and a beneficiary. |
| Ordinary SharesSEC Table I · non-derivative | IndirectBy Child #1 | 843 |
Reported balance
Holding disclosure · report date 2024-08-02 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 843 |
| Ordinary SharesSEC Table I · non-derivative | IndirectBy Child #2 | 843 |
Reported balance
Holding disclosure · report date 2024-08-02 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 843 |
| Ordinary SharesSEC Table I · non-derivative | IndirectBy Child #3 | 843 |
Reported balance
Holding disclosure · report date 2024-08-02 · row 7
Holding and transaction disclosures are not merged.
1 source rowRow 7 · Balance 843 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares issued upon the settlement of performance-vesting restricted stock units granted on August 2, 2021 and earned dividend equivalents.
F2: Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units that vested on August 2, 2024.
F3: Represents shares withheld for taxes upon the vesting of restricted stock units previously reported on Table I.
F4: These shares are held in the Jeffrey S. Parkhill 2021 Irrevocable Trust, of which the insider is the trustee and a beneficiary.
F5: Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
F6: The performance share units vested on August 2, 2024.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 22, 2021 Filed Jun 28, 2021 21:21 UTC | Medtronic plc MDT · Entity 2888 | GiftOrdinary Shares | 238 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-020754 · form4.xml · nonDerivative · entry 1 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,985 Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 22:11 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 605 | $124.47 | $75,304.35 |
DisclosureSEC source: 0001127602-21-020242 · form4.xml · nonDerivative · entry 1 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,223 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · balance_after: This balance increased by 272 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| May 04, 2021 Filed May 6, 2021 18:51 UTC | AMERICAN EXPRESS CO AXP · Entity 2839 | GrantShare Equivalent Units · Derivative | 1,339.136 | $149.35 | $199,999.96 |
DisclosureSEC source: 0001127602-21-015675 · form4.xml · derivative · entry 1 PARKHILL KAREN L · CIK 0001527660 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,691.079 Underlying: Common Stock · 1,339.136 shares Expires not disclosed F1 · derivative.exercise_price: Each Share Equivalent Unit reflects the value of one common share. F2 · kind: The reported Share Equivalent Units were awarded pursuant to the Company's 2003 Share Equivalent Unit Plan for Directors and will be settled in cash following termination of service as a Director. F3 · derivative.exercise_date: The Share Equivalent Units are convertible immediately and have no expiration date. F3 · derivative.expiration_date: The Share Equivalent Units are convertible immediately and have no expiration date. F4 · balance_after: Includes Share Equivalent Units acquired pursuant to a dividend reinvestment feature of the Directors' Deferred Compensation Plan and/or the 2003 Share Equivalent Unit Plan for Directors. Read SEC document |
| March 15, 2021 Filed Mar 16, 2021 21:19 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 632 | $119.12 | $75,283.84 |
DisclosureSEC source: 0001127602-21-010841 · form4.xml · nonDerivative · entry 1 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,556 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · balance_after: This balance increased by 291 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| December 15, 2020 Filed Dec 16, 2020 22:34 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 670 | $114.33 | $76,601.10 |
DisclosureSEC source: 0001127602-20-031597 · form4.xml · nonDerivative · entry 1 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,897 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · balance_after: This balance increased by 201 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| October 09, 2020 Filed Oct 14, 2020 22:58 UTC | Medtronic plc MDT · Entity 2888 | GrantPerformance Share Units · Derivative | 20,243 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-026958 · form4.xml · derivative · entry 1 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,243 Underlying: Performance Share Units · 20,243 shares Expires not disclosed F1 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F2 · shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 20,243 shares will be issued. The actual number of shares to be issued could range from a low of 4,049 at minimum performance to a high of 40,486 shares at maximum performance. If minimum performance metrics are not met, such PSUs may vest at 0 shares. F3 · derivative.exercise_date: Vests on August 3, 2023. F3 · derivative.expiration_date: Vests on August 3, 2023. Read SEC document |
| September 15, 2020 Filed Sep 16, 2020 21:40 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 702 | $107.78 | $75,661.56 |
DisclosureSEC source: 0001127602-20-025235 · form4.xml · nonDerivative · entry 1 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,366 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 21:05 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 50,378 | $0.00 Strike: $97.33 | $0.00 |
DisclosureSEC source: 0001127602-20-022914 · form4.xml · derivative · entry 7 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,378 Underlying: Ordinary Shares · 50,378 shares Expires 2030-08-03 F2 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 21:05 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 1,575 | $0.00 Strike: $97.33 | $0.00 |
DisclosureSEC source: 0001127602-20-022914 · form4.xml · derivative · entry 6 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,575 Underlying: Ordinary Shares · 1,575 shares Expires 2030-08-03 F2 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 21:05 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 83,123 | $0.00 Strike: $97.33 | $0.00 |
DisclosureSEC source: 0001127602-20-022914 · form4.xml · derivative · entry 5 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,123 Underlying: Ordinary Shares · 83,123 shares Expires 2030-08-03 F2 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 21:05 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 9,042 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-022914 · form4.xml · nonDerivative · entry 1 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,068 F1 · kind: The restrictions on these restricted stock units shall lapse 100% on the third anniversary of the Grant Date. Read SEC document |
| July 31, 2020 Filed Aug 3, 2020 21:55 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 6,339 | $96.48 | $611,586.72 |
DisclosureSEC source: 0001127602-20-022603 · form4.xml · nonDerivative · entry 1 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,026 F1 · balance_after: This balance increased by 255 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| June 01, 2020 Filed Jun 5, 2020 20:33 UTC | Medtronic plc MDT · Entity 2888 | GiftOrdinary Shares | 305 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-019008 · form4.xml · nonDerivative · entry 6 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Child #3 Disclosed balance after: 605 Read SEC document |
| June 01, 2020 Filed Jun 5, 2020 20:33 UTC | Medtronic plc MDT · Entity 2888 | GiftOrdinary Shares | 305 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-019008 · form4.xml · nonDerivative · entry 5 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,110 Read SEC document |
| June 01, 2020 Filed Jun 5, 2020 20:33 UTC | Medtronic plc MDT · Entity 2888 | GiftOrdinary Shares | 305 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-019008 · form4.xml · nonDerivative · entry 4 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Child #2 Disclosed balance after: 605 Read SEC document |
| June 01, 2020 Filed Jun 5, 2020 20:33 UTC | Medtronic plc MDT · Entity 2888 | GiftOrdinary Shares | 305 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-019008 · form4.xml · nonDerivative · entry 3 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,415 Read SEC document |
| June 01, 2020 Filed Jun 5, 2020 20:33 UTC | Medtronic plc MDT · Entity 2888 | GiftOrdinary Shares | 305 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-019008 · form4.xml · nonDerivative · entry 2 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Child #1 Disclosed balance after: 605 Read SEC document |
| June 01, 2020 Filed Jun 5, 2020 20:33 UTC | Medtronic plc MDT · Entity 2888 | GiftOrdinary Shares | 305 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-019008 · form4.xml · nonDerivative · entry 1 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,720 F1 · balance_after: This balance increased by 633 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| May 05, 2020 Filed May 7, 2020 19:00 UTC | AMERICAN EXPRESS CO AXP · Entity 2839 | GrantShare Equivalent Units · Derivative | 2,325.58 | $86.00 | $199,999.88 |
DisclosureSEC source: 0001127602-20-015722 · form4.xml · derivative · entry 1 PARKHILL KAREN L · CIK 0001527660 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,325.58 Underlying: Common Stock · 2,325.58 shares Expires not disclosed F1 · derivative.exercise_price: Each Share Equivalent Unit reflects the value of one common share. F2 · kind: The reported Share Equivalent Units were awarded pursuant to the Company's 2003 Share Equivalent Unit Plan for Directors and will be settled in cash following termination of service as a Director. F3 · derivative.exercise_date: The Share Equivalent Units are convertible immediately and have no expiration date. F3 · derivative.expiration_date: The Share Equivalent Units are convertible immediately and have no expiration date. Read SEC document |
| August 01, 2019 Filed Aug 2, 2019 22:39 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 5,533 | $102.37 | $566,413.21 |
DisclosureSEC source: 0001127602-19-025937 · form4.xml · nonDerivative · entry 1 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,392 Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 22:06 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 1,615 | $0.00 Strike: $103.26 | $0.00 |
DisclosureSEC source: 0001127602-19-025560 · form4.xml · derivative · entry 6 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,615 Underlying: Ordinary Shares · 1,615 shares Expires 2029-07-29 F3 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 22:06 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 94,739 | $0.00 Strike: $103.26 | $0.00 |
DisclosureSEC source: 0001127602-19-025560 · form4.xml · derivative · entry 5 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,739 Underlying: Ordinary Shares · 94,739 shares Expires 2029-07-29 F3 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 22:06 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 14,204 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-025560 · form4.xml · nonDerivative · entry 1 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,925 F1 · kind: The restrictions on these restricted stock units shall lapse 100% on the third anniversary of the Grant Date if the Company's cumulative non-GAAP diluted earnings per share ("EPS") growth during the 36-month period ending on the last day of the Company's fiscal year 2022 equals or exceeds a 3% cumulative compound annual growth rate, as determined by the Compensation Committee. F2 · balance_after: This balance increased by 214 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| June 21, 2019 Filed Jun 27, 2019 21:28 UTC | Medtronic plc MDT · Entity 2888 | GiftOrdinary Shares | 300 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-022967 · form4.xml · nonDerivative · entry 4 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Child #3 Disclosed balance after: 300 Read SEC document |
| June 21, 2019 Filed Jun 27, 2019 21:28 UTC | Medtronic plc MDT · Entity 2888 | GiftOrdinary Shares | 300 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-022967 · form4.xml · nonDerivative · entry 3 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Child #2 Disclosed balance after: 300 Read SEC document |
| June 21, 2019 Filed Jun 27, 2019 21:28 UTC | Medtronic plc MDT · Entity 2888 | GiftOrdinary Shares | 300 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-022967 · form4.xml · nonDerivative · entry 2 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Child #1 Disclosed balance after: 300 Read SEC document |
| June 21, 2019 Filed Jun 27, 2019 21:28 UTC | Medtronic plc MDT · Entity 2888 | GiftOrdinary Shares | 900 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-022967 · form4.xml · nonDerivative · entry 1 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,507 Read SEC document |
| June 20, 2019 Filed Jun 21, 2019 21:43 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 6,945 | $99.26 | $689,360.70 |
DisclosureSEC source: 0001127602-19-022538 · form4.xml · nonDerivative · entry 1 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,407 F1 · balance_after: This balance increased by 672 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| January 09, 2019 Filed Jan 9, 2019 17:28 UTC | Medtronic plc MDT · Entity 2888 | PurchaseOrdinary Shares | 3,000 | $83.87 | $251,610.00 |
DisclosureSEC source: 0001127602-19-001696 · form4.xml · nonDerivative · entry 1 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,680 F1 · balance_after: This balance increased by 309 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| July 30, 2018 Filed Aug 1, 2018 20:03 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 1,695 | $0.00 Strike: $89.08 | $0.00 |
DisclosureSEC source: 0001127602-18-024247 · form4.xml · derivative · entry 3 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,695 Underlying: Ordinary Shares · 1,695 shares Expires 2028-07-30 F3 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| July 30, 2018 Filed Aug 1, 2018 20:03 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 85,067 | $0.00 Strike: $89.08 | $0.00 |
DisclosureSEC source: 0001127602-18-024247 · form4.xml · derivative · entry 2 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,067 Underlying: Ordinary Shares · 85,067 shares Expires 2028-07-30 F3 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| July 30, 2018 Filed Aug 1, 2018 20:03 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 14,089 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-024247 · form4.xml · nonDerivative · entry 1 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,371 F1 · kind: The restrictions on these restricted stock units shall lapse 100% on the third anniversary of the Grant Date if the Company's cumulative non-GAAP diluted earnings per share ("EPS") growth during the 36-month period ending on the last day of the Company's fiscal year 2021 equals or exceeds a 3% cumulative compound annual growth rate, as determined by the Compensation Committee. F2 · balance_after: This balance increased by 243 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| June 20, 2018 Filed Jun 21, 2018 20:49 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 6,527 | $86.13 | $562,170.51 |
DisclosureSEC source: 0001127602-18-021696 · form4.xml · nonDerivative · entry 1 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,039 F1 · balance_after: This balance increased by 1,036 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 18:56 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 1,191 | $0.00 Strike: $83.97 | $0.00 |
DisclosureSEC source: 0001127602-17-024708 · form4.xml · derivative · entry 3 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,191 Underlying: Ordinary Shares · 1,191 shares Expires 2027-07-31 F3 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 18:56 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 53,988 | $0.00 Strike: $83.97 | $0.00 |
DisclosureSEC source: 0001127602-17-024708 · form4.xml · derivative · entry 2 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,988 Underlying: Ordinary Shares · 53,988 shares Expires 2027-07-31 F3 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 18:56 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 13,497 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-024708 · form4.xml · nonDerivative · entry 1 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,530 F1 · kind: The restrictions on these restricted stock units shall lapse 100% on the third anniversary of the Grant Date if the Company's cumulative non-GAAP diluted earnings per share growth during the 36 month period ending on the last day of the Company's fiscal year 2020 equals or exceeds a 3% cumulative compound annual growth rate, as determined by the Compensation Committee. F2 · balance_after: This balance increased by 252 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| June 20, 2017 Filed Jun 21, 2017 21:09 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 7,047 | $88.82 | $625,914.54 |
DisclosureSEC source: 0001127602-17-022008 · form4.xml · nonDerivative · entry 1 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,781 F1 · balance_after: This balance increased by 1,039 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.